ClinicalTrials.Veeva

Menu

Follow-up Visit of High Risk Infants (FU)

N

NICHD Neonatal Research Network

Status

Enrolling

Conditions

Infant, Low Birth Weight
Infant, Newborn
Infant, Small for Gestational Age
Infant, Premature

Treatments

Other: No Intervention

Study type

Observational

Funder types

NETWORK
NIH

Identifiers

NCT00009633
UG1HD040689 (U.S. NIH Grant/Contract)
NICHD-NRN-0007
UG1HD021364 (U.S. NIH Grant/Contract)
UG1HD112097 (U.S. NIH Grant/Contract)
UG1HD040492 (U.S. NIH Grant/Contract)
UG1HD027904 (U.S. NIH Grant/Contract)
UG1HD053089 (U.S. NIH Grant/Contract)
U24HD095254 (U.S. NIH Grant/Contract)
UG1HD112100 (U.S. NIH Grant/Contract)
UG1HD034216 (U.S. NIH Grant/Contract)
UG1HD027851 (U.S. NIH Grant/Contract)
UG1HD068244 (U.S. NIH Grant/Contract)
UG1HD027853 (U.S. NIH Grant/Contract)
UG1HD068278 (U.S. NIH Grant/Contract)
UG1HD087226 (U.S. NIH Grant/Contract)
UG1HD027880 (U.S. NIH Grant/Contract)
UG1HD068263 (U.S. NIH Grant/Contract)
UG1HD112079 (U.S. NIH Grant/Contract)
UG1HD112093 (U.S. NIH Grant/Contract)
UG1HD053109 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants born in participating network centers receive neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, 2012 were seen at 18-22 months corrected age). Data regarding pregnancy and neonatal outcome are collected prospectively. The goal is to identify potential maternal and neonatal risk factors that may affect infant neurodevelopment.

Full description

The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort study in which surviving extremely low birth-weight infants undergo neurodevelopmental, neurosensory and functional assessments at 22-26 months corrected age (Infants born prior to July 1, 2012 were seen at 18-22 month corrected age). The goal of the study is to identify potential maternal and neonatal risk factors that may affect infant neurodevelopment, including:

  • Evaluating development of motor skills, cognitive skills, language and behavior
  • Determining mortality and the prevalence of specific medical conditions
  • Assessing the relationship between growth and neurodevelopmental outcome
  • Assessing the relationship between the socioeconomic status and developmental outcome
  • Assessing the use of special support services and early intervention programs by this population
  • Evaluating the need for follow-up at school age.

The scheduled evaluations collect: demographic information; socioeconomic status; medical history; medications; medical equipment required; growth data; a detailed neurologic examination; Bayley Scales of Infant Development (mental, motor, infant behavior); Child Behavior Checklist.

A sub-study will assess a reference group comprised of a limited number of healthy term infants born in Network centers to meet the following three aims: 1) to avoid potential ascertainment biases due to examiner expectations when only extremely preterm or other high-risk infants are assessed 2) in the absence of well-developed norms for the Bayley Scales, to define thresholds for impairment based on data for a representative sample of healthy children born at term in our centers and concurrently assessed by the same examiners as for our high-risk infants; and 3) to help identify and address when "drift" occurs over time in conducting and scoring Bayley assessments.

Enrollment

68,000 estimated patients

Sex

All

Ages

18 to 26 months old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  • Infants inborn at NRN centers
  • <27 weeks gestational age
  • Infants enrolled in one or more additional NICHD NRN Follow-up studies. For infants that do not meet the inclusion criteria above, inclusion and exclusion criteria are determined by the criteria for the additional trial(s). In these cases, infants that are larger than 1,000 grams and/or older than 27 weeks may be included in the FU Study.

Note: These inclusion criteria were changed as of 1/1/2008. Prior to this date, infants with birth weights between 401 and 1500 grams who were admitted to NRN NICUs within 14 days of birth were included in the database.

Trial design

68,000 participants in 1 patient group

Registry Cohort
Description:
Registry Cohort
Treatment:
Other: No Intervention

Trial contacts and locations

31

Loading...

Central trial contact

Abhik Das, PhD; Susan R Hintz, MD, MS Epi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems